🏛️ Verified NIH Record • Updated 2026-01-08
A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis (NCT06431373)
A Phase 3 Randomized, Double-Masked, Placebo-Controlled Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Active, Non-Infectious Intermediate-, Posterior-, and Panuveitis
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic Sponsor: Priovant Therapeutics, Inc.
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Who can join: Review the eligibility criteria below.
Location: Clinical Trial Site — Phoenix, Arizona
Age range: 18 Years to 75 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (107 Sites)
Showing the first 25 of 107 sites.
- Clinical Trial Site — Phoenix, Arizona
- Clinical Trial Site — Phoenix, Arizona
- Clinical Trial Site — Bakersfield, California
- Clinical Trial Site — Beverly Hills, California
- Clinical Trial Site — Fullerton, California
- Clinical Trial Site — Irvine, California
- Clinical Trial Site — La Jolla, California
- Clinical Trial Site — Los Angeles, California
- Clinical Trial Site — Los Angeles, California
- Clinical Trial Site — Modesto, California
- Clinical Trial Site — Sacramento, California
- Clinical Trial Site — Aurora, Colorado
- Clinical Trial Site — Denver, Colorado
- Clinical Trial Site — Fort Lauderdale, Florida
- Clinical Trial Site — St. Petersburg, Florida
- Clinical Trial Site — Chicago, Illinois
- Clinical Trial Site — Oak Park, Illinois
- Clinical Trial Site — Carmel, Indiana
- Clinical Trial Site — Prairie Village, Kansas
- Clinical Trial Site — Baltimore, Maryland
- Clinical Trial Site — Boston, Massachusetts
- Clinical Trial Site — Waltham, Massachusetts
- Clinical Trial Site — Ann Arbor, Michigan
- Clinical Trial Site — Detroit, Michigan
- Clinical Trial Site — Detroit, Michigan
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Uveitis, Posterior
Explore by condition: All Uveitis, Posterior clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.